Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Chugai Pharmaceutical Co....

    OTC: CHGCF · Real-Time Price · USD
    54.57
    -0.26 (-0.47%)
    At close: Jun 13, 2025, 3:54 PM

    Chugai Pharmaceutical Statistics

    Share Statistics

    Chugai Pharmaceutical has 1.65B shares outstanding. The number of shares has increased by 0.01% in one year.

    Shares Outstanding

    n/a
    		 1.65B

    Shares Change (YoY)

    n/a
    		 0.01%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 613.32M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.05M, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.05M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 124.03

    Valuation Ratios

    The PE ratio is 27.89 and the forward PE ratio is 0.17. Chugai Pharmaceutical's PEG ratio is 1.47.

    PE Ratio

    n/a
    		 27.89

    Forward PE

    n/a
    		 0.17

    PS Ratio

    n/a
    		 9.23

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 5.68

    P/FCF Ratio

    n/a
    		 27.51

    PEG Ratio

    n/a
    		 1.47
    Financial Ratio History

    Enterprise Valuation

    Chugai Pharmaceutical has an Enterprise Value (EV) of 10,263.4B.

    EV / Sales

    n/a
    		 8.77

    EV / EBITDA

    n/a
    		 18.94

    EV / EBIT

    n/a
    		 22.93

    EV / FCF

    n/a
    		 26.14

    Financial Position

    The company has a current ratio of 5.53, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 5.53

    Quick Ratio

    n/a
    		 4.7

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -527.75

    Financial Efficiency

    Return on Equity is 20.37% and Return on Invested Capital is 20.16%.

    Return on Equity

    n/a
    		 20.37%

    Return on Assets

    n/a
    		 17.54%

    Return on Invested Capital

    n/a
    		 20.16%

    Revenue Per Employee

    n/a
    		 $232,911,062.48

    Profits Per Employee

    n/a
    		 $77,062,674.09

    Employee Count

    n/a
    		 5,026

    Asset Turnover

    n/a
    		 0.53

    Inventory Turnover

    n/a
    		 1.41

    Taxes

    Income Tax

    n/a
    		 155.72B

    Effective Tax Rate

    n/a
    		 28.68%

    Stock Price Statistics

    The stock price has increased by 80.6% in the last 52 weeks. The beta is 0.67, so Chugai Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 80.6%

    50-Day Moving Average

    n/a
    		 52.62

    200-Day Moving Average

    n/a
    		 47.37

    Relative Strength Index (RSI)

    n/a
    		 52.69

    Average Volume (20 Days)

    n/a
    		 3,797

    Income Statement

    In the last 12 months, Chugai Pharmaceutical had revenue of 1,170.6B and earned 387.32B in profits. Earnings per share was 235.35.

    Revenue

    n/a
    		 1,170.6B

    Gross Profit

    n/a
    		 831.2B

    Operating Income

    n/a
    		 542B

    Net Income

    n/a
    		 387.32B

    EBITDA

    n/a
    		 542B

    EBIT

    n/a
    		 542B

    Earnings Per Share (EPS)

    n/a
    		 235.35
    Full Income Statement

    Balance Sheet

    The company has 540.2B in cash and 0 in debt, giving a net cash position of 540.2B.

    Cash & Cash Equivalents

    n/a
    		 540.2B

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 2,060.2B

    Working Capital

    n/a
    		 1,185.9B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 447.6B and capital expenditures -54.9B, giving a free cash flow of 392.7B.

    Operating Cash Flow

    n/a
    		 447.6B

    Capital Expenditures

    n/a
    		 -54.9B

    Free Cash Flow

    n/a
    		 392.7B

    FCF Per Share

    n/a
    		 238.62
    Full Cash Flow Statement

    Margins

    Gross margin is 71.01%, with operating and profit margins of 46.3% and 33.09%.

    Gross Margin

    n/a
    		 71.01%

    Operating Margin

    n/a
    		 46.3%

    Pretax Margin

    n/a
    		 46.39%

    Profit Margin

    n/a
    		 33.09%

    EBITDA Margin

    n/a
    		 46.3%

    EBIT Margin

    n/a
    		 46.3%

    FCF Margin

    n/a
    		 33.55%

    Dividends & Yields

    CHGCF pays an annual dividend of $1.43, which amounts to a dividend yield of 2.22%.

    Dividend Per Share

    n/a
    		 $1.43

    Dividend Yield

    n/a
    		 2.22%

    Dividend Growth (YoY)

    n/a
    		 218.06%

    Payout Ratio

    n/a
    		 81.54%

    Earnings Yield

    n/a
    		 3.59%

    FCF Yield

    n/a
    		 3.63%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CHGCF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $2939.52

    Lynch Upside

    n/a
    		 5261.15%

    Graham Number

    n/a
    		 2473.52

    Graham Upside

    n/a
    		 4411.25%

    Stock Splits

    The last stock split was on Jul 6, 2020. It was a forward split with a ratio of 3:1.

    Last Split Date

    n/a
    		 Jul 6, 2020

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:1

    Scores

    Altman Z-Score

    n/a
    		 3.27

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist